Prof. Hai Bo Mou, MD, PhD
Oncologist
-
Position :Director of Medical Oncology, Shulan (Hangzhou) Hospital; Deputy Director of the Clinical Drug Base Institution Office
-
Specialty :Comprehensive treatment of lung cancer, gastrointestinal tumors, and hepatopancreatic tumors
-
Affiliated Hospital :Shulan (Hangzhou) Hospital
-
Department :Precision immunotherapy and targeted therapy for malignant tumors, management of refractory and recurrent cases
Overview
The Oncology Department provides comprehensive cancer management including: neoadjuvant, adjuvant, conversion, palliative, and curative chemotherapy; precision medicine-guided molecular targeted therapy, biological immunotherapy, and endocrine therapy; hyperthermia, thermochemotherapy, and hyperthermic intraperitoneal chemotherapy; cancer screening for high-risk populations; standardized cancer pain management; chemotherapy-induced nausea prevention protocols (“nocarboplatin unit”); nutritional support for advanced cancer; and hospice care.
Achievements and Experience
Professor Mou specializes in the comprehensive treatment of lung cancer, gastrointestinal tumors, and hepatopancreatic tumors, with extensive experience in precision immunotherapy and targeted therapy for malignant tumors, as well as in managing refractory and recurrent cases. He is well-versed in the development process of oncology drugs and has led several domestic and international clinical trials of new drugs.
He has directed and participated in numerous national and provincial research projects. His research findings have been frequently presented at academic conferences, and he has published over 10 SCI-indexed papers as the first or corresponding author. He was honored with the titles of “Excellent Oncologist Trusted by Hangzhou Citizens in 2016” and “Zhejiang Province’s First Warm-hearted Doctor in 2019.”